ArticleBMC cancer2025
Automated contouring of gross tumor volume lymph nodes in lung cancer by deep learning.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThe precise contouring of gross tumor volume lymph nodes (GTVnd) is an essential step in clinical target volume delineation. This study aims to propose and evaluate a deep learning model for segmenting GTVnd specifically in lung cancer, representing one of the pioneering investigations into automated segmentation of GTVnd specifically for lung cancer.
methodNinety computed tomography (CT) scans of patients with stage Ш-Ⅳ small cell lung cancer (SCLC) were collected, of which 75 patients were assembled into a training dataset and 15 were used in a testing dataset. A new segmentation model was constructed to enable the automatic and accurate delineation of the GTVnd in lung cancer. This model integrates a contextual cue enhancement module and an edge-guided feature enhancement decoder. The contextual cues enhancement module was used to enforce the consistency of the contextual cues encoded in the deepest feature, and the edge-guided feature enhancement decoder was used to obtain edge-aware and edge-preserving segmentation predictions. The model was quantitatively evaluated using the three-dimensional Dice Similarity Coefficient (3D DSC) and the 95th Hausdorff Distance (95HD). Additionally, comparative analysis was conducted between predicted treatment plans derived from auto-contouring GTVnd and established clinical plans.
resultsThe ECENet achieved a mean 3D DSC of 0.72 ± 0.09 and a 95HD of 6.39 ± 4.59 mm, showing significant improvement compared to UNet, with a DSC of 0.46 ± 0.19 and a 95HD of 12.24 ± 13.36 mm, and nnUNet, with a DSC of 0.52 ± 0.18 and a 95HD of 9.92 ± 6.49 mm. Its performance was intermediate, falling between mid-level physicians, with a DSC of 0.81 ± 0.06, and junior physicians, with a DSC of 0.68 ± 0.10. And the clinical and predicted treatment plans were further compared. The dosimetric analysis demonstrated excellent agreement between predicted and clinical plans, with average relative deviation of < 0.17% for PTV D2/D50/D98, < 3.5% for lung V30/V20/V10/V5/Dmean, and < 6.1% for heart V40/V30/Dmean. Furthermore, the TCP (66.99% ± 0.55 vs. 66.88% ± 0.45) and NTCP (3.13% ± 1.33 vs. 3.25% ± 1.42) analyses revealed strong concordance between predicted and clinical outcomes, confirming the clinical applicability of the proposed method.
conclusionThe proposed model could achieve the automatic delineation of the GTVnd in the thoracic region of lung cancer and showed certain advantages, making it a potential choice for the automatic delineation of the GTVnd in lung cancer, particularly for young radiation oncologists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.